👋🏼  Welcome back

Seeds of Change: Medicinal Cannabis and Epilepsy Management

Epilepsy, a neurological condition characterised by recurrent seizures, poses unique challenges for patients and healthcare professionals managing symptoms. While traditional treatments play a pivotal role, the limitations of some medications have spurred increased interest in alternative therapies, notably medicinal cannabis.

Research indicates that cannabinoids in medicinal cannabis may contribute significantly to managing epilepsy symptoms, including:

Seizure Control

CBD, a prominent cannabinoid, has shown the capacity to regulate nerve cell activity and modulate the release of signalling chemicals in the brain. This regulatory function appears to decrease the frequency and intensity of seizures.

Neuroinflammation Management

Cannabinoids, such as THC and CBD, demonstrate anti-inflammatory effects, potentially slowing down the progression of epilepsy by reducing neuroinflammation—a crucial factor in nerve damage.

Neurological Symptom Management

Beyond inflammation and pain, medical cannabis treatments may address other distressing symptoms commonly associated with neurological conditions, including cognitive disturbances.


Potential Neuroprotective Effects:

Some studies suggest that medicinal cannabis may also possess neuroprotective properties, offering protection against nervous system damage and potentially mitigating the impact of epilepsy on overall neurological function.

By fostering awareness and understanding of medicinal cannabis, we want to empower healthcare professionals to confidently manage epilepsy and explore diverse possibilities for their patient’s better quality of life.

References
  1. Perucca E. Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?. J Epilepsy Res. 2017;7(2):61-76. Published 2017 Dec 31. doi:10.14581/jer.17012
  1. Singh K, Bhushan B, Chanchal DK, et al. Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review. Behav Neurol. 2023;2023:8825358. Published 2023 Oct 12. doi:10.1155/2023/8825358
  1. Walter L, Stella N. Cannabinoids and neuroinflammation. Br J Pharmacol. 2004;141(5):775-785. doi:10.1038/sj.bjp.0705667